Severe Vasomotor Symptom Associated With Menopause

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Severe Vasomotor Symptom Associated With Menopause trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 1/2

NCT07118891

Study Evaluating ABCL635 for Vasomotor Symptoms of Menopause

The purpose of this study is to evaluate the effects of single and multiple doses of ABCL635 administered by subcutaneous (SC) injection to healthy men and to p…

Canada136 participantsStarted 2025-06-23

Treatment: ABCL635, Placebo

All recent trials (14 shown)

CompletedPhase 2

NCT06812754

A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Chinese Women Going Through Menopause

Hot flashes are the most common reason women going through menopause seek medical attention. Hormone replacement therapy, or HRT, is most often prescribed to tr…

China150 participantsStarted 2025-03-10

Treatment: Fezolinetant, Placebo

CompletedPhase 3

NCT04234204

A Study to Find Out if Fezolinetant Helps Reduce Moderate to Severe Hot Flashes in Women in Asia Going Through Menopause

This study is for women in menopause with moderate to severe hot flashes. Menopause, a normal part of aging, is the time of a woman's last period. Hot flashes c…

China302 participantsStarted 2020-03-17

Treatment: Fezolinetant, Placebo

Severe Vasomotor Symptom Associated With Menopause

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Study Evaluating ABCL635 for Vasomotor Symptoms of Menopause

All recent trials (14 shown)

A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Chinese Women Going Through Menopause

A Study to Find Out if Fezolinetant Helps Reduce Moderate to Severe Hot Flashes in Women in Asia Going Through Menopause

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Study Evaluating ABCL635 for Vasomotor Symptoms of Menopause

All recent trials (14 shown)

A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Chinese Women Going Through Menopause

A Study to Find Out if Fezolinetant Helps Reduce Moderate to Severe Hot Flashes in Women in Asia Going Through Menopause

A Study to Find Out if Fezolinetant Helps Reduce Moderate to Severe Hot Flashes in Women Going Through Menopause - 2

A Study to Find Out if Fezolinetant Helps Reduce Moderate to Severe Hot Flashes in Women Going Through Menopause

A Survey Evaluating Prevalence, Severity and Associated Factors in East Asian Women With Moderate-to-severe Menopause-re…

Dose-ranging, PK, Safety, Efficacy Study of Osanetant in Patients With Moderate/Severe VMS Associated With Menopause

A Study of BAY3427080 (NT-814) in the Treatment of Moderate to Severe Post-menopausal Vasomotor Symptoms

Post Marketing Surveillance To Observe Safety And Efficacy Of Duavive

Dose-Finding Safety and Efficacy Trial of Org50081 (Esmirtazapine) in the Treatment of Vasomotor Symptoms (46101/P06459/…

Dose-Finding Safety and Efficacy Trial of Org 50081 (Esmirtazapine) in the Treatment of Vasomotor Symptoms (177001/P0647…

Evaluate the Effect of Omega-3 vs Soy Isoflavones in Postmenopausal Women With Moderate to Severe Vasomotor Symptoms

Desvenlafaxine Succinate (Pristiq): Postmarketing Surveillance Study Among Filipino Patients

Study Evaluating Bazedoxifene/Conjugated Estrogen Combinations in Vasomotor Symptoms Associated With Menopause